Reimbursement for oral anticancer drugs.
Current policies regarding reimbursement for oral anticancer drugs are discussed. Several legislative options that might expand such coverage are reviewed.
Bailes
J S
JS
Clinical Practice Committee, American Society of Clinical Oncology, Washington, DC.
D000284:Administration, Oral; D000970:Antineoplastic Agents / Q000191:economics*; D007349:Insurance, Health, Reimbursement / Q000331:legislation & jurisprudence; D007356:Insurance, Pharmaceutical Services / Q000331:legislation & jurisprudence; D008484:Medicaid / Q000331:legislation & jurisprudence; D006278:Medicare / Q000331:legislation & jurisprudence; D014481:United States
D000970:Antineoplastic Agents